Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s.

[1]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[2]  W. Laskey,et al.  Creatine kinase release after catheter-based coronary intervention. , 1997, Catheterization and cardiovascular diagnosis.

[3]  K. Endresen,et al.  Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. , 1996, Journal of the American College of Cardiology.

[4]  L. Roussel,et al.  Stent implantation in acute myocardial infarction. , 1996, The American journal of cardiology.

[5]  R. Califf,et al.  Relation between activated clotting time during angioplasty and abrupt closure. , 1996, Circulation.

[6]  F. Neumann,et al.  Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. , 1996, Heart.

[7]  E. Topol,et al.  Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures. , 1996, Circulation.

[8]  S. Kimmel,et al.  Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice , 1995 .

[9]  R. Califf,et al.  Percutaneous revascularization of chronic coronary occlusions: an overview. , 1995, Journal of the American College of Cardiology.

[10]  R. Califf,et al.  Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. , 1994, Journal of the American College of Cardiology.

[11]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[12]  C. Gaos,et al.  Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. , 1994, Journal of the American College of Cardiology.

[13]  L. Klein,et al.  Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty? , 1992, Catheterization and cardiovascular diagnosis.

[14]  H. Hecht,et al.  Lesion morphology and coronary angioplasty: current experience and analysis. , 1992, Journal of the American College of Cardiology.

[15]  William Grossman,et al.  Cardiac Catheterization, Angiography, and Intervention , 1990 .

[16]  E J Topol,et al.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.

[17]  F. Loop,et al.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.

[18]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[19]  M. Hadamitzky,et al.  Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. , 1997, Journal of the American College of Cardiology.